Jennifer A. Daniel-Johnson

发表

Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial

B. Tilley, K. Inaba, E. Fox, 2015, Transfusion.

Survival Advantage and PaO2 Threshold in Severe Traumatic Brain Injury

G. O’Keefe, M. Vavilala, Jin Wang, 2013, Journal of neurosurgical anesthesiology.

Iron replacement therapy in the routine management of blood donors

J. A. Hopkins, Sarah M Arceo, S. Leitman, 2012, Transfusion.

Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial.

Samuel M. Galvagno, Henry E. Wang, A. Arkin, 2019, Annals of emergency medicine.

A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high‐titer ABO antibodies

W. Flegel, K. Quillen, Willy A. Flegel, 2011, Transfusion.

Building a New Transfusion Service

J. Hess, Erin E Tuott, R. Metcalf, 2017, American journal of clinical pathology.

Probiotic‐associated high‐titer anti‐B in a group A platelet donor as a cause of severe hemolytic transfusion reactions

P. Scheinberg, H. Klein, H. Alter, 2009, Transfusion.

How do I approach ABO‐incompatible hematopoietic progenitor cell transplantation? (CME)

J. Schwartz, Jennifer A Daniel-Johnson, Jennifer A. Daniel-Johnson, 2011, Transfusion.

Therapeutic plasma exchange for the treatment of anti‐NMDA receptor encephalitis

B. Stotler, J. Schwartz, H. Pham, 2011, Journal of clinical apheresis.